Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/12/078051
CTRI/2024/12/078051
Completed
Post Marketing Surveillance

A Sensorial Assessment of the 10 percent Niacinamide face serum in comparison with the 3 marketed products

Honasa Consumer Limited1 site in 1 country100 target enrollmentStarted: December 23, 2024Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Post Marketing Surveillance
Status
Completed
Sponsor
Honasa Consumer Limited
Enrollment
100
Locations
1
Primary Endpoint
X% users observed the better parameters
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

Sensorial Assessment of the Test Product(T) with 3 comparators

Test Product- 10 percent Niacinamide face serum, and Comprators (A, B, C)

Route of Administration: Topical

Frequency: Once

Data Processing: Average Parameters for Test (Avg from all the three sets), V/s Parameters for Comparator A, V/s Parameters for Comparator B, V/s Parameters for Comparator C, V/s Test.

Study Design

Study Type
Pms
Allocation
Na
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Either gender- Male or Female with age 18 to 60
  • •Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
  • •For whom the investigator considers that the compliance will be correct.
  • •Having signed a Consent Form.
  • •Should be able to read and write (in English, Hindi or local language).
  • •Having valid proof of identity and age.

Exclusion Criteria

  • •Pregnant of Lactating mothers
  • •Subject in an exclusion period or participating in another food, cosmetic or therapeutic study.

Outcomes

Primary Outcomes

X% users observed the better parameters

Time Frame: 0 and 5 mins

Secondary Outcomes

  • Not Applicable(Not Applicable)

Investigators

Sponsor
Honasa Consumer Limited
Sponsor Class
Pharmaceutical industry-Indian
Responsible Party
Principal Investigator
Principal Investigator

Dr Robin Chugh

CCFT Laboratories

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Check Efficacy of 3% Niacinamide & Rice Water Toner for skin Brightening
CTRI/2025/02/080241Pureplay Skin Sciences Pvt Ltd36
Recruiting
Phase 2
Pilot study of the efficacy of nicotinamide (vitamin B3) in Leber's hereditary optic neuropathy - NICOLHON
2025-524343-13-00Centre Hospitalier Universitaire D'Angers13
Suspended
Not Applicable
48-hours Moisturization Potential of Piramal Lacto calamine Retinol Gel
CTRI/2024/12/078451Piramal Pharma Limited32
Completed
Not Applicable
Skin Saftey test of Cipla Papaya Sunscream Spf 60
CTRI/2025/02/080242Cipla Health Limited24
Not yet recruiting
Not Applicable
skin saftey test of BlisDrop Toxicity S-1 Foaming HW, Toxicity S-2 Gel HW
CTRI/2025/09/095316Blisdrop Ecom Pvt Ltd24